Ventas (VTR) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Ventas, Inc. (VTR) insider buying and selling: 1 purchase, 26 sales
139 Form 4 Table I transactions filed with the SEC by Ventas, Inc. insiders between 2025-09-04 and 2026-10-15 (15-month history): 1 open-market purchase and 26 sales, plus 112 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $23.6M by Cafaro Debra A on 2025-10-30.
Ventas insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Ventas insiders filed 1 purchase worth $197k and 20 sales worth $42.7M on the open market. The net balance is on the sell side: $42.5M more sold than bought.
The biggest buyer was Embler Michael J (Director): $197k in 1 purchase, the only buyer. The biggest seller was Cafaro Debra A (Chairman and CEO): $33.9M in 10 sales, out of 5 different sellers.
The largest trade of the period was a sale of $23.6M on Oct 30, 2025, by Cafaro Debra A (Chairman and CEO), under a 10b5-1 plan. Form 4 on sec.gov (0001215188-25-000008).
Of the 20 sales, 19 (95%, $39.7M) carry the 10b5-1 plan flag on the Form 4, meaning they were scheduled months ahead; the other one does not.
The last three months show 0 purchases and 0 sales, against 1 and 1 in the three before. The latest purchase is from Jun 3, 2026; the latest sale from May 14, 2026.
Against its sector (Real Estate, 30 companies with an insider page on this site), over the same dates the median is 3.5 sales and 0 purchases on the open market. Ventas has more sales than 27 of the other 29, ranks 3 of 30 by net dollars sold, and 10 of the 30 have at least one purchase, Ventas included.
The 20 most important trades
The only open-market purchase first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 139 VTR trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-05 | Embler Michael J | Director | $197k | P — Open-market purchase | SEC |
| 2025-10-30 | 2025-11-03 | Cafaro Debra A | Chairman and CEO | $23.6M | S — Open-market sale (scheduled 10b5-1)8 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.00 to $74.66, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F4 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $73.87 to $74.68, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F6 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $72.05 to $74.71, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F8 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.00 to $74.68, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-10-20 | 2025-10-22 | Cafaro Debra A | Chairman and CEO | $15.7M | S — Open-market sale (scheduled 10b5-1)3 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $71.00 to $71.50, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. | SEC |
| 2025-11-17 | 2025-11-19 | Cafaro Debra A | Chairman and CEO | $3.3M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.00 to $79.1703, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-02-11 | 2026-02-13 | Roberts Carey S. | EVP and GC | $3.0M | S — Open-market saleForm 4 footnoteF1 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $84.99 to $85.091, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-12 | 2025-11-14 | Probst Robert F | EVP and CFO | $2.6M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.71 to $76.9376 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-01-02 | 2026-01-06 | Probst Robert F | EVP and CFO | $2.3M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.73 to $77.66 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-03 | 2025-11-03 | Cafaro Debra A | Chairman and CEO | $1.5M | S — Open-market sale (scheduled 10b5-1)4 Form 4 footnotesF3 The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F9 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $73.86 to $74.1829, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F10 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $72.86 to $74.17, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-05 | 2025-11-06 | Cafaro Debra A | Chairman and CEO | $1.4M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F3 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.00 to $75.61, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-04 | 2025-11-06 | Cafaro Debra A | Chairman and CEO | $859k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.00 to $75.15, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-02-06 | 2026-02-10 | Cafaro Debra A | Chairman and CEO | $849k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 6 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $82.00 to $82.76, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-12-01 | 2025-12-03 | Cafaro Debra A | Chairman and CEO | $831k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $80.13 to $80.81, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-02-02 | 2026-02-03 | Cafaro Debra A | Chairman and CEO | $802k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF5 The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F6 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $77.18 to $78.4251, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-01-02 | 2026-01-06 | Cafaro Debra A | Chairman and CEO | $797k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.7835 to $77.66, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-10-01 | 2025-10-02 | Cafaro Debra A | Chairman and CEO | $725k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $69.8327 to $70.472, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-09-02 | 2025-09-04 | Cafaro Debra A | Chairman and CEO | $700k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $67.4096 to $68.12, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-04 | 2025-11-06 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | $294k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.99 to $75.11, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-18 | 2025-11-20 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | $222k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.99 to $80.20, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-10-01 | 2025-10-02 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | $179k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $69.9931 to $70.4706, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-11-19 | 2025-11-20 | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | $179k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F3 The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.99 to $80.2441, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | SEC |
The period balance: money in, money out
Across the Form 4 filings submitted between Sep 4, 2025 and Oct 15, 2026, Ventas, Inc. open-market activity adds up to 1 purchase worth $197k and 26 sales worth $60.2M. The net balance is $60.0M on the sell side.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Ventas, Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 82 | $15.1M |
| S | Open-market sale | 26 | $60.2M |
| F | Tax withholding (shares surrendered for taxes) | 16 | $18.4M |
| M | Option exercise | 14 | $47.3M |
| P | Open-market purchase | 1 | $197k |
| Total | Everything filed in the period | 139 | $141.2M |
All 139 rows carry an amount: the column adds up what was filed, no estimates. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 18 distinct people or entities have filed Ventas, Inc. transactions: 1 bought on the open market and 5 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Cafaro Debra A | Chairman and CEO | 30 | — | $51.0M (13) | 2026-02-13 |
| Probst Robert F | EVP and CFO | 7 | — | $4.9M (2) | 2026-02-13 |
| Roberts Carey S. | EVP and GC | 5 | — | $3.0M (1) | 2026-02-13 |
| Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 14 | — | $1.1M (9) | 2026-05-05 |
| Embler Michael J | Director | 7 | $197k (1) | — | 2026-10-15 |
| Rakowich Walter C | Director | 2 | — | $104k (1) | 2026-05-15 |
| Martino Roxanne M | Director | 13 | — | — | 2026-10-15 |
| Smith Maurice S | Director | 13 | — | — | 2026-10-15 |
Shown here are the 8 who moved the most money, out of 18. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Nov 2025: 0 purchases and 12 sales, worth $10.5M. 7 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 3 | $871k |
| Oct 2025 | 0 | $0 | 4 | $40.1M |
| Nov 2025 | 0 | $0 | 12 | $10.5M |
| Dec 2025 | 0 | $0 | 1 | $831k |
| Jan 2026 | 0 | $0 | 2 | $3.1M |
| Feb 2026 | 0 | $0 | 3 | $4.7M |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 1 | $104k |
| Jun 2026 | 1 | $197k | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Ventas, Inc. (VTR) analysis page →
Other Real Estate companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
18 of the 19 sales in the table are flagged as scheduled (10b5-1 plan): signed months ahead and executed automatically, so they say nothing about what the insider thinks today. Ventas's single open-market purchase (code P) is the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Oct 15, 2026, and a Form 4 arrives up to two business days after the trade.
19 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.